Last week, property portal REA Group (REA) reported one of those sensational financial results. But could REA be vulnerable to new disruptive business models driven by AI. Let’s explore this, plus insights from the brokers and the company’s outlook.
If I don’t want any more Aussie banks, can I get an ETF that gives me access to US and European banks? How does TPG’s capital return of $3bn work? What do the major brokers think of Wisetech? Is AMP paying a dividend and is it franked or unfranked?
Following the lead of the USA, the Australian share market recorded its fourth consecutive month of gains in July. All sectors, with the exception of financials, finished in the “green”. Year to date, the market is up 7.2% and with dividends included, 9.0%.
How did the broker analysts respond to RIO’s profit announcement? Which ETFs are best suited for SMSFs? How will RBA rate cuts affect my investment strategy? When is RIO paying its interim dividend and is there a DRP?
You’re ultimately responsible for the investment performance. So, how can you determine whether you’re cutting it as an investment manager? And what should you do if you’re not?
Can I buy an ETF to invest in the “Magnificent 7”? What do the brokers think of gold miner Northern Star Resources? Why did Macquarie’s share price drop by $10? With the aussie dollar hitting 66c, is it too late to hedge my international shares?
Here’s a portfolio of stocks for the “scaredy-cats”, who are those investors who think President Trump will give a lie to his nickname (“TACO”) and do something really crazy that will seriously impact global markets.
If I invest with Vanguard with their Personal Investor Account, do I have the same protection I would enjoy by buying with my broker and with my HIN? Why doesn’t gas pipeline operator APA frank its distribution? What do the brokers think of Seek? Does the Australian share market have a “bank earnings season”?
Accounting software company Xero (XRO) has launched a $200m share purchase plan (SPP). Shareholders can purchase up to $30,000 of Xero shares at a price no higher than $176.00 per share. The offer follows Xero’s US$2.5m purchase of Melio, a leading US small and medium (SMB) bill pay platform.
As a long standing shareholder in Ramsay Health Care, should I continue to hang on? How has the Australian share market performed compared to other major world share markets? Why is Xero doing a share purchase plan rather than a rights issue, which is fairer to all shareholders? What are “long/short” funds, and can you recommend any?
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.